Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Active, Not Recruiting

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

NCT03876769

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Children s Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • City of Hope National Medical Duarte, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

NCT02862275

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +9 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Moffitt Cancer Center-International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN

NCT04317105

Conditions
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +5 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Texas at Austin Austin, Texas, United States
  • University of Texas Medical Branch Galveston, Texas, United States
  • UT MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma

NCT03502733

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • UT MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial

NCT05554341

Conditions
Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, Neoplasms, +4 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Presbyterian Intercommunity Hospital Whittier, California, United States
View all 125 locations
View Trial Details

Related conditions